Cancers, Vol. 12, Pages 2889: Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology

Cancers, Vol. 12, Pages 2889: Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology Cancers doi: 10.3390/cancers12102889 Authors: Paola Amero Soumen Khatua Cristian Rodriguez-Aguayo Gabriel Lopez-Berestein A relatively new paradigm in cancer therapeutics is the use of cancer cell–specific aptamers, both as therapeutic agents and for targeted delivery of anticancer drugs. After the first therapeutic aptamer was described nearly 25 years ago, and the subsequent first aptamer drug approved, many efforts have been made to translate preclinical research into clinical oncology settings. Studies of aptamer-based technology have unveiled the vast potential of aptamers in therapeutic and diagnostic applications. Among pediatric solid cancers, brain tumors are the leading cause of death. Although a few aptamer-related translational studies have been performed in adult glioblastoma, the use of aptamers in pediatric neuro-oncology remains unexplored. This review will discuss the biology of aptamers, including mechanisms of targeting cell surface proteins, various modifications of aptamer structure to enhance therapeutic efficacy, the current state and challenges of aptamer use in neuro-oncology, and the potential therapeutic role of aptamers in pediatric brain tumors.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research